Application of glycyrrhizic acid on treating dilated cardiomyopathy cardiac remodeling and cardiac dysfunction
A technology of dilated cardiomyopathy and glycyrrhizic acid, applied in the field of medicine, can solve problems such as cardiac remodeling
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0030] Materials and Methods
[0031] 1. Reagents and instruments
[0032] 1. Main reagents and medicines
[0033] Doxorubicin (Doxorubicin, DOX): Shenzhen Wanle Pharmaceutical Co., Ltd., batch number: 20081025;
[0034] Glycyrrhizin (Glycyrrhizin): Merck Company, Catalog NO: 356780-5GM;
[0035] 2. Experimental animals
[0036] SPF grade ICR mice (male, 10 weeks old, weighing 26-30 g) were purchased from Beijing Weitong Lihua Experimental Animal Technology Co., Ltd., animal certificate number SCXK (Beijing) 2008-0001. They were raised in the Experimental Animal Center of the Institute of Materia Medica, Chinese Academy of Medical Sciences, with constant temperature and humidity, and free diet.
[0037] 2. Experimental method
[0038] 1. Preparation of doxorubicin-induced cardiomyopathy model mice
[0039] The ICR mice were sterilized with 75% alcohol in the abdomen, and a single intraperitoneal injection of doxorubicin (10 mg / kg) was used to establish the model. After ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com